CD8A and neoplasm: Furthermore, antibody-mediated CD8+ T-cell depletion significantly diminished the therapeutic effects of the anti-PD-L1 mAb on F. nucleatum-supplemented tumor-bearing mice based on tumor volume (Fig. 3e–g).